Female sexual dysfunction: a review
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20241098Keywords:
Female sexual dysfunction, Hypoactive sexual desire disorder, Genitopelvic pain disorder, DyspareuniaAbstract
Sexual health is an important aspect of human life and to maintain a healthy and happy sexual life a positive integration of physical, social as well and psychological domains is very important. Any alteration in any of these domains can lead to sexual dysfunction which can significantly affect the quality of life of a couple. Many couples live with the problem and suffer silently due to shyness, stigmas, and social norms related to the issue. Many times even the treating medical professionals also do not screen for the sexual issues due to inadequate knowledge and training related to sexual dysfunction further increasing the burden of the disorder which remain undiagnosed. Sexual dysfunction can affect both men and women. Since the sexual cycle is complex in women both diagnosing and treating the female sexual dysfunction can often be challenging. Routine screening, meticulous workup and multidisciplinary approach is usually required to diagnose and mange sexual disorders.
Metrics
References
Education and treatment in human sexuality: the training of health professionals. Report of a WHO meeting. World Health Organ Tech Rep Ser. 1975;(572):5-33.
Clegg M, Towner A, Wylie K. Should questionnaires of female sexual dysfunction be used in routine clinical practice? Maturitas. 2012;72(2):160-4.
Amidu N, Owiredu WK, Woode E, Addai-Mensah O, Gyasi-Sarpong KC, Alhassan A. Prevalence of male sexual dysfunction among Ghanaian populace: myth or reality? Int J Impot Res. 2010;22(6):337-42.
Amidu N, Owiredu WK, Woode E, Addai-Mensah O, Quaye L, Alhassan A, et al. Incidence of sexual dysfunction: a prospective survey in Ghanaian females. Reprod Biol Endocrinol. 2010;8:106.
Mitchell KR, Jones KG, Wellings K, Johnson AM, Graham CA, Datta J, et al. Estimating the Prevalence of Sexual Function Problems: The Impact of Morbidity Criteria. J Sex Res. 2016;53(8):955-67.
McCool ME, Zuelke A, Theurich MA, Knuettel H, Ricci C, Apfelbacher C. Prevalence of Female Sexual Dysfunction Among Premenopausal Women: A Systematic Review and Meta-Analysis of Observational Studies. Sex Med Rev. 2016;4(3):197-212.
Wylie K, Mimoun S. Sexual response models in women. Maturitas. 2009;63:112-5.
Basson R. Are our definitions of women’s desire, arousal and sexual pain disorders too broad and our definition of orgasmic disorder too narrow? J Sex Marital Ther. 2002;28:289-300.
Meston CM, Buss DM. Why humans have sex. Arch Sex Behav. 2007;36(4):477-507.
Both S, Everaerd W and Laan E. Desire emerges from excitement: a psychophysiological perspective on sexual motivation. In: Janssen E (ed.) The psychophysiology of sex. Bloomington, IA: Indiana University Press. 2007;327-39.
Cain VS, Johannes CB, Avis NE, Mohr B, Schocken M, Skurnick J, et al. Sexual functioning and practices in a multi-ethnic study of midlife women: baseline results from SWAN. J Sex Res. 2003;40(3):266-76.
Klusmann D. Sexual motivation and the duration of partnership. Arch Sex Behav. 2002;31(3):275-87.
Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Arch Sex Behav. 2010;39(2):221-39.
Brecher EM. Review of Human Sexual Inadequacy. J Sex Res. 1970;6(3):247-50.
Levine SB. Reexploring the concept of sexual desire. J Sex Marital Ther. 2002;28(1):39-51.
Marthol H, Hilz MJ. Female sexual dysfunction: a systematic overview of classification, pathophysiology, diagnosis and treatment. Fortschr Neurol Psychiatr. 2004;72(3):121-35.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fifth edition Arlington, TX: American Psychiatric Publishing. 2013.
Shen WW, Urosevich Z, Clayton DO. Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors. J Reprod Med. 1999;44(6):535-42.
Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med. 1985;47(4):339-51.
Tarcan T, Park K, Goldstein I, Maio G, Fassina A, Krane RJ, et al. Histomorphometric analysis of age-related structural changes in human clitoral cavernosal tissue. J Urol. 1999;161(3):940-4.
Guze SB. Diagnostic and statistical manual of mental disorders. 4th ed. 2006.
Bitzer J, Giraldi A, Pfaus J. Sexual desire and hypoactive sexual desire disorder in women. Introduction and overview. Standard operating procedure (SOP Part 1). J Sex Med. 2013;10(1):36-49.
Kingsberg SA, Rezaee RL. Hypoactive sexual desire in women. Menopause. 2013;20(12):1284-300.
Rathore C, Henning OJ, Luef G, Radhakrishnan K. Sexual dysfunction in people with epilepsy. Epilepsy Behav. 2019;100(PtA):106495.
Park K, Moreland RB, Goldstein I, Atala A, Traish A. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Commun. 1998;249(3):612-7.
Traish A, Moreland RB, Huang YH, Kim NN, Berman J, Goldstein I. Development of human and rabbit vaginal smooth muscle cell cultures: effects of vasoactive agents on intracellular levels of cyclic nucleotides. Mol Cell Biol Res Commun. 1999;2(2):131-7.
Bestepe E, Cabalar M, Kucukgoncu S, Calıkusu C, Ornek F, Yayla V, et al. Sexual dysfunction in women with migraine versus tension-type headaches: a comparative study. Int J Impot Res. 2011;23(3):122-7.
Carosa E, Sansone A, Jannini EA. Female sexual dysfunction for the endocrinologist. Europ J Endocrinol. 2020;182,R101-16.
Sarrel PM. Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of post-menopausal women. Int J Impot Res. 1998;10(2):S91-3.
Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med. 1985;47(4):339-51.
Davis SR. Androgens and female sexuality. J Gend Specif Med. 2000;3(1):36-40.
Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369(9561):597-611.
Ambler DR, Bieber EJ, Diamond MP. Sexual function in elderly women: a review of current literature. Rev Obstet Gynecol. 2012;5(1):16-27.
Nazarpour S, Simbar M, Tehrani FR. Factors affecting sexual function in menopause: a review article. Taiwan J Obstetr Gynecol. 2016;55:480-87.
Jannini EA, Nappi RE. Couplepause: a new paradigm in treating sexual dysfunction during menopause and andropause. Sexual Medicine Rev. 2018;6:384-95.
Nastri CO, Lara LA, Ferriani RA, Rosa-E-Silva AC, Figueiredo JB, Martins WP. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2013;(6):CD009672.
Taylor HS, Tal A, Pal L, Li F, Black DM, Brinton EA, et al. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS). JAMA Intern Med. 2017;177(10):1471-9.
Barut MU, Çoksüer H, Sak S, Bozkurt M, Ağaçayak E, Hamurcu U, et al. Evaluation of Sexual Function in Women with Hypogonadotropic Hypogonadism Using the Female Sexual Function Index (FSFI) and the Beck Depression Inventory (BDI). Med Sci Monit. 2018;24:5610-18.
Ros C, Alobid I, Balasch J, Mullol J, Castelo-Branco C. Turner's syndrome and other forms of congenital hypogonadism impair quality of life and sexual function. Am J Obstet Gynecol. 2013;208(6):484.e1-6.
Kagan R, Kellogg-Spadt S, Parish SJ. Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause. Drugs Aging. 2019;36(10):897-908.
Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and North American Menopause Society. Menopause. 2014;21(10):1063-8.
Uloko M, Rahman F, Puri LI, Rubin RS. The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review. Int J Impot Res. 2022;34(7):635-41.
Wahlin-Jacobsen S, Pedersen AT, Kristensen E, Laessøe NC, Lundqvist M, Cohen AS, et al. Is there a correlation between androgens and sexual desire in women? J Sex Med. 2015;12(2):358-73.
Basson R, Brotto LA, Petkau AJ, Labrie F. Role of androgens in women's sexual dysfunction. Menopause. 2010;17(5):962-71.
Randolph JF Jr, Zheng H, Avis NE, Greendale GA, Harlow SD. Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition. J Clin Endocrinol Metab. 2015;100(1):258-66.
Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab. 2019;104(10):4660-66.
Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, et al. Safety and efficacy of a testosterone patch for treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Internal Med. 2005;165:1582-9.
Basaria S, Dobs AS. Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women. J Clin Endocrinol Metabol. 2006;91(12):4743-52.
Simon JA, Goldstein I, Kim NN, Davis SR, Kellogg-Spadt S, Lowenstein L, et al. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review. Menopause. 2018;25(7):837-47.
Jannini EA, Buisson O, Rubio-Casillas A. Beyond the G-spot: clitourethrovaginal complex anatomy in female orgasm. Nat Rev Urol. 2014;11(9):531-8.
Traish AM, Kim N, Min K, Munarriz R, Goldstein I. Role of androgens in female genital sexual arousal: receptor expression, structure, and function. Fertil Steril. 2002;77(4):S11-8.
Balercia G, Boscaro M, Lombardo F, Carosa E, Lenzi A, Jannini EA. Sexual symptoms in endocrine diseases: psychosomatic perspectives. Psychother Psychosom. 2007;76(3):134-40.
Galdiero M, Pivonello R, Grasso LF, Cozzolino A, Colao A. Growth hormone, prolactin, and sexuality. J Endocrinol Invest. 2012;35(8):782-94.
De Rosa M, Zarrilli S, Vitale G, Di Somma C, Orio F, Tauchmanova' L, et al. Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence. J Clin Endocrinol Metab. 2004;89(2):621-5.
Mazzilli R, Zamponi V, Olana S, Mikovic N, Cimadomo D, Defeudis G, et al. Erectile dysfunction as a marker of endocrine and glycemic disorders. J Endocrinol Invest. 2022;45(8):1527-34.
Kadioglu P, Yalin AS, Tiryakioglu O, Gazioglu N, Oral G, Sanli O, et al. Sexual dysfunction in women with hyperprolactinemia: a pilot study report. J Urol. 2005;174:1921-5.
Krysiak R, Drosdzol-Cop A, Skrzypulec-Plinta V, Okopien B. Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study. Endocrine. 2016;53(1):291-8.
Ashfaq M, Haroon M, Zeeshan A, Yasser MSA. "Proton pump inhibitors therapy and risk of hyperprolactinemia with associated sexual disorders" Endocrine Regulations. 2022;56(2):134-47.
Krysiak R, Okopień B. Sexual Functioning in Hyperprolactinemic Patients Treated with Cabergoline or Bromocriptine. Am J Ther. 2019;26(4):e433-40.
Kalsi AK, Halder A, Jain M, Chaturvedi PK, Sharma JB. Prevalence and reproductive manifestations of macroprolactinemia. Endocrine. 2019;63(2):332-40.
Gabrielson AT, Sartor RA, Hellstrom WJG. The Impact of Thyroid Disease on Sexual Dysfunction in Men and Women. Sex Med Rev. 2019;7(1):57-70.
Krysiak R, Drosdzol-Cop A, Skrzypulec-Plinta V, Okopien B. Sexual function and depressive symptoms in young women with thyroid autoimmunity and subclinical hypothyroidism. Clin Endocrinol (Oxf). 2016;84(6):925-31.
Atis G, Dalkilinc A, Altuntas Y, Atis A, Caskurlu T, Ergenekon E. Sexual dysfunction in women with clinical hypothyroidism and subclinical hypothyroidism. J Sex Med. 2010;7(7):2583-90.
Atis G, Dalkilinc A, Altuntas Y, Atis A, Gurbuz C, Ofluoglu Y, Cil E, Caskurlu T. Hyperthyroidism: a risk factor for female sexual dysfunction. J Sex Med. 2011;8(8):2327-33.
Oppo A, Franceschi E, Atzeni F, Taberlet A, Mariotti S. Effects of hyperthyroidism, hypothyroidism, and thyroid autoimmunity on female sexual function. J Endocrinol Invest. 2011;34(6):449-53.
Pasquali D, Maiorino MI, Renzullo A, Bellastella G, Accardo G, Esposito D, Barbato F, Esposito K. Female sexual dysfunction in women with thyroid disorders. J Endocrinol Invest. 2013;36(9):729-33.
Keskin FE, Özkaya HM, Ortaç M, Salabaş E, Kadıoğlu A, Kadıoğlu P. Sexual function in women with Cushing's Syndrome: A controlled study. Turk J Urol. 2018;44(4):287-93.
Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 1999;341(14):1013-20.
Buster JE. Managing female sexual dysfunction. Fertil Steril. 2013;100(4):905-15.
Bitzer J, Giraldi A, Pfaus J. Sexual desire and hypoactive sexual desire disorder in women. Introduction and overview. Standard operating procedure (SOP Part 1). J Sex Med. 2013;10(1):36-49.
Fugl-Meyer KS, Bohm-Starke N, Damsted Petersen C, Fugl-Meyer A, Parish S, Giraldi A. Standard operating procedures for female genital sexual pain. J Sex Med. 2013;10(1):83-93.
McCool-Myers, M., Theurich, M., Zuelke, A. et al. Predictors of female sexual dysfunction: a systematic review and qualitative analysis through gender inequality paradigms. BMC Women's Health. 2018;18:108.
Plouffe L Jr. Screening for sexual problems through a simple questionnaire. Am J Obstet Gynecol. 1985;151(2):166-9.
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208.
Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28(4):317-30.
Berman JR. Physiology of female sexual function and dysfunction. Int J Impot Res. 2005;17(1):S44-51.
Annon J. The PLISSIT Model: A Proposed Conceptual Scheme for the Behavioural Treatment of Sexual Problems. J Sex Education Therapy. 1976;2:1-15.
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Gynecology. Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet Gynecol. 2019;134(1):e1-18.
Kuile MM, Both S, Lankveld JJDM. Sexual dysfunctions in women. In P. Sturmey and M. Hersen (Eds.), Handbook of evidence-based practice in clinical psychology. Adult disorders. John Wiley and Sons, Inc. 2015;2:413-35.
McMullen S, Rosen RC. Self-administered masturbation training in the treatment of primary orgasmic dysfunction. J Consult Clin Psychol. 1979;47(5):912-8.
Riley AJ, Riley EJ. A controlled study to evaluate directed masturbation in the management of primary orgasmic failure in women. Br J Psychiatr. 1978;133:404-9.
Kershaw V, Jha S. Female Sexual dysfunction. Obstetr Gynecologist. 2022;24:12-23.
Downloads
Published
How to Cite
Issue
Section
